Comorbidities and Factors Determining Medical Expenses and Length of Stay for Admitted COVID-19 Patients in Korea
Open Access
- 1 May 2021
- journal article
- research article
- Published by Taylor & Francis in Risk Management and Healthcare Policy
- Vol. ume 14, 2021-2033
Abstract
Purpose: No previous investigations of coronavirus disease 2019 (COVID-19) have estimated medical expenses, length of stay, or factors influencing them using administrative datasets. This study aims to fill this research gap for the Republic of Korea, which has over 10,000 confirmed COVID-19 cases. Patients and Methods: Using the nationwide health insurance claims data of 7590 confirmed COVID-19 patients, we estimated average medical expenses and inpatient days per patient, and performed multivariate negative binomial, and gamma regressions to determine influencing factors for higher outcomes. Results: According to the results, COVID-19 patients with history of ICU admission, chest CT imaging, lopinavir/ritonavir and hydroxychloroquine use stayed longer in the hospital and spent more on medical expenses, and anti-hypertensive drugs were insignificantly associated with the outcomes. Female patients stayed longer in the hospital in the over 65 age group but spent less in medical expenses that the 20– 39 group. In the 40– 69 age group, patients with health insurance stayed longer in the hospital and spent more on medical expenses than those aged over 65 years. Comorbidities did not affect outcomes in most age groups. Conclusion: In summary, contrary to popular beliefs, medical expenses and length of hospitalization were mostly influenced by age, and not by comorbidities, anti-viral, or anti-hypertensive drugs. Thus, responses should focus on infection prevention and control rather than clinical countermeasures.Keywords
This publication has 25 references indexed in Scilit:
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Estimation Of Direct Medical Costs Of Middle East Respiratory Syndrome Coronavirus Infection: A Single-Center Retrospective Chart Review StudyInfection and Drug Resistance, 2019
- Direct and Indirect Costs of Chronic Obstructive Pulmonary Disease in KoreaTuberculosis and Respiratory Diseases, 2019
- Economic burden and its associated factors of hospitalized patients infected with A (H7N9) virus: a retrospective study in Eastern China, 2013–2014Infectious Diseases of Poverty, 2016
- Quality of Life and Economic Burden of Respiratory Disease in Asia-Pacific—Asia-Pacific Burden of Respiratory Diseases StudyValue in Health Regional Issues, 2016
- Prevalence of Chronic Obstructive Lung Disease in Korea Using Data from the Fifth Korea National Health and Nutrition Examination SurveyKorean Journal of Family Medicine, 2015
- Direct Medical Cost of Influenza-Related Hospitalizations among Severe Acute Respiratory Infections Cases in Three Provinces in ChinaPLOS ONE, 2013
- Economic Burden and Epidemiology of Pneumonia in Korean Adults Aged over 50 YearsJournal of Korean Medical Science, 2013
- Economic burden of asthma in KoreaAllergy and Asthma Proceedings, 2011
- Duration of symptom onset to hospital admission and admission to discharge or death in SARS in mainland China: a descriptive studyTropical Medicine & International Health, 2009